| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protagonist Therapeutics, Inc. (PTGX) has 8 insiders with recent SEC Form 4 filings, including 7 buys and 5 sells. PTGX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 523.5K | $60.06M | - | |
| Other | 106.8K | $12.25M | - | |
| CFO | 60.8K | $6.97M | - | |
| Dir | 7.8K | $897.8K | - | |
| Dir | 7.8K | $897.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2020 | Khosla Chaitan Phd | Director | Sale+OE | 2,499 | $17.19 | $42,952.06 | -100% | |
| Mar 12, 2020 | Selick Harold E | Director | Buy | 12,000 | $6.70 | $80,400.00 | +362.5% | |
| Dec 3, 2019 | Giraudo Bryan73 | Director | Buy | 8,000 | $5.70 | $45,620.00 | New | |
| Dec 3, 2019 | Gupta Suneel | EVP Clinical Operations | Buy | 30,000 | $5.13 | $153,900.00 | +153.8% | |
| Dec 3, 2019 | Kalkofen Donald A. | Chief Financial Officer | Buy | 1,175 | $5.10 | $5,986.88 | +191.7% | |
| Dec 3, 2019 | Patel Dinesh V Ph D | President And CEO | Buy | 30,000 | $5.62 | $168,500.00 | +3.9% | |
| Aug 6, 2019 | Liu David Y | Chief Scientific Officer | Sell | 3,395 | $8.85 | $30,044.05 | -6.4% | |
| Aug 6, 2019 | Patel Dinesh V Ph D | President And CEO | Sell | 10,792 | $8.85 | $95,535.10 | -2.8% | |
| Mar 1, 2019 | Liu David Y | Chief Scientific Officer | Sell | 810 | $8.03 | $6,504.30 | -1.6% | |
| Mar 1, 2019 | Patel Dinesh V Ph D | President And CEO | Sell | 2,183 | $8.03 | $17,529.49 | -0.6% |